One in three people will be diagnosed with cancer during their lifetime. Even though progress has been made in the diagnosis and treatment of cancer, we still need to learn much more about the underlying biology of this disease in order to change its general perception from a deadly to a curable disease.
The CCB research focus
Cancers develop because of complicated interactions between our genes, our environment and chance. The sequencing of the human genome and the recent development of high-throughput methods for genomic, transcriptomic and proteomic analyses and functional genomics have rapidly advanced our possibilities for understanding relationships between genes and diseases. In particular, systems biology is evolving as a promising field within cancer research. While cell biologists and translational cancer researchers who work together with clinicians, traditionally have worked in separate laboratories, an interpretation of the complex dynamics of cancer requires the close cooperation between these disciplines, as well as computational biology, due to the highly complex data sets.
Centre for Cancer Biomedicine aims to combine large-scale and detailed biology research to increase the understanding of the complex dynamics of cancer evolution. The aim of CCB is to use the obtained information for molecularly assisted medicine: The novel biomarkers of cancer can be transferred into diagnostic biomedical tests, and their combined information will direct the choice of therapeutic regime, theragnostics, for the individual cancer patient. The ultimate aim for CCB is to translate basic and patient-oriented research into advanced cancer biomedicine.
The CCB research subjects are
- Functional analyses of potential biomarkers in cancer
- Cell signalling in cancer
- Genomics & Epigenomics
- Advanced bioinformatics and development of novel imaging tools for cancer research